Detalhe da pesquisa
1.
Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation.
Oncologist
; 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141396
2.
HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons.
Anticancer Drugs
; 34(10): 1196-1201, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689646
3.
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics.
Anticancer Drugs
; 34(6): 747-762, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378136
4.
Structure of a bacterial energy-coupling factor transporter.
Nature
; 497(7448): 272-6, 2013 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23584587
5.
Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.
Hum Mol Genet
; 25(9): 1875-84, 2016 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941397
6.
The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer.
Carcinogenesis
; 35(9): 2062-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788237
7.
Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer.
Cancer Med
; 13(8): e7032, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651178
8.
Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy.
Int Immunopharmacol
; 131: 111823, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508094
9.
Exploring the potential for groundwater-related ground deformation in Southern New South Wales, Australia.
Sci Total Environ
; 895: 165167, 2023 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379933
10.
Adaptation to climate change through strategic integration of long fallow into cropping system in a dryland Mediterranean-type environment.
Sci Total Environ
; 880: 163230, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023813
11.
The allelic regulation of tumor suppressor ADARB2 in papillary thyroid carcinoma.
Endocr Relat Cancer
; 30(1)2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305508
12.
The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer.
J Cancer
; 14(6): 952-965, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151388
13.
Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis.
Front Immunol
; 14: 1251645, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799725
14.
Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.
J Cancer Res Clin Oncol
; 149(5): 2029-2039, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35829744
15.
Opportunities and challenges of immune checkpoint inhibitors for extensive-stage small-cell lung cancer.
Cancer Innov
; 1(2): 183-193, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090647
16.
Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology.
Chin Med
; 17(1): 140, 2022 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528679
17.
Surface Water-Groundwater Interaction in the Guanzhong Section of the Weihe River Basin, China.
Ground Water
; 57(4): 647-660, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30582150
18.
Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study.
Onco Targets Ther
; 12: 1681-1689, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30881023
19.
Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
Oncotarget
; 8(6): 9442-9450, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038462
20.
Temporal and Spatial Variations of Drought in China: Reconstructed from Historical Memorials Archives during 1689-1911.
PLoS One
; 11(2): e0148072, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26836807